Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-037881
Filing Date
2022-06-17
Accepted
2022-06-17 16:25:39
Documents
1
Period of Report
2022-06-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3993
  Complete submission text file 0001209191-22-037881.txt   5323
Mailing Address 427 PARK ST. CHARLOTTESVILLE VA 22902
Business Address 427 PARK ST. CHARLOTTESVILLE VA 22902 925-368-8508
Acumen Pharmaceuticals, Inc. (Issuer) CIK: 0001576885 (see all company filings)

EIN.: 364108129 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O CARA THERAPEUTICS, INC. 1 PARROTT DRIVE SHELTON CT 06484
Business Address
Ives Jeffrey L. (Reporting) CIK: 0001614096 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40551 | Film No.: 221024214